Next-Gen Drug Significantly Prevents Return of and Death From Endometrial Cancer

NEW YORK, Oct. 26, 2026 /PRNewswire/ -- A new drug is effective at decreasing recurrence of and death from endometrial cancer, a landmark international study shows. The drug, called sacituzumab tirumotecan (sac-TMT), attaches to a protein on the surface of tumor cells and then delivers a...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.